why choose us

First received: May 08, 2023

Clinical Trial: The Application of Transcriptomics in the Treatment of Ulcerative Colitis With Ustekinumab

Study Status: Completed

Recruit Status: RECRUITING

Condition: Ulcerative Colitis

Study Type: OBSERVATIONAL


Official Title: The Application of Transcriptomics for Establishing Potential Prognostic Markers of Response to Treatment of Ulcerative Colitis With Ustekinumab

Brief Summary: The investigators hope that the present study will highlight new transcriptomic prognostic markers of response to Ustekinumab with the ultimate goal of individualizing treatment and making a more targeted selection of UC patients who will benefit from this biological agent.

Read more